All Work

Chris Lange

Why Analysts Are Slashing Tableau Software Expectations

Tableau Software Inc. (NYSE: DATA) saw its earnings report turn into an unexpected loss, and the company posted lower than expected license revenues. The news was bad enough that it looks like the entire…

Chris Lange · 11 years ago

Analysts Cooling on Match After Q4 Earnings

Match reported its fourth-quarter financial results on Tuesday, but after the report, analysts began to reconsider how they viewed the company.

Chris Lange · 11 years ago

How Analysts Value Gilead Now After Earnings

After Gilead Sciences reported fourth-quarter financial results on Tuesday, analysts weighed in on this biotech giant and in what direction it might go next.

Chris Lange · 11 years ago

Analysts Get Even More Bullish in Take-Two

24/7 Wall St. has reviewed a few analyst calls that came after the company Take-Two Interactive Software posted its results and most were fairly positive.

Chris Lange · 11 years ago

Top 4 BioPharma Movers of the Week

Over the past week, Alere and a few biotech other companies made absolutely massive runs, either up and down.

Chris Lange · 11 years ago

Mapi Pharma Closes in on IPO

Mapi Pharma expects to price more than 3 million shares in the range of $15 to $17 in an initial public offering valued up to about $61 million.

Chris Lange · 11 years ago

How Silver Lake Saved Symantec Earnings

Symantec reported its fiscal third-quarter financial results after the markets closed on Thursday, as well as a huge investment by Silver Lake.

Chris Lange · 11 years ago

Kohl’s Falls Flat on Holiday Quarter Update

Kohl's slumped in Thursday’s session following a financial update for its current fiscal year. The numbers fell well below what analysts had expected.

Chris Lange · 11 years ago